Off-label therapies for alopecia areata expand options beyond approved treatments, balancing access, safety, monitoring, and equity while evidence gaps complicate shared decision making and long-term outcomes.

Administrative barriers and benefit design delays in metabolic care restrict access to GLP-1 and incretin therapies, worsening diabetes and obesity outcomes while widening equity gaps.

Healthy aging prioritizes function, independence, and dignity through routine functional assessment, deprescribing, fall prevention, sensory support, caregiver engagement, and team-based, community-connected care aligned with patient goals.

Long-term data show some irritable bowel syndrome patients later develop inflammatory bowel disease, underscoring risk-stratified follow-up, red flag recognition, and targeted testing to prevent delayed diagnosis.

Acute optic neuritis demands rapid escalation to plasma exchange in high-risk or steroid-refractory patients, preserving vision by removing pathogenic antibodies before irreversible optic nerve damage occurs.

In suspected metastatic breast cancer, tissue biopsy confirms diagnosis, updates receptor status, guides targeted therapy, prevents misclassification, enables trial access, and supports timely, personalized treatment decisions.

A new biopsychosocial risk score predicts persistent, widespread, or high-impact chronic pain, enabling earlier personalized care, safer prescribing, and better health system planning for vulnerable patients.

Emerging evidence suggests menopausal hormone therapy enhances tirzepatide-driven weight loss in postmenopausal women, offering a synergistic, hormone-informed approach to obesity, metabolic risk reduction, and healthier aging.

Polycystic ovary syndrome requires individualized, stepwise care addressing menstrual irregularity, androgen symptoms, fertility goals, metabolic risk, and mental health through long-term, coordinated multidisciplinary management.

A large Swedish study finds COVID-19 vaccination does not reduce fertility or childbirth rates, providing strong evidence to counter misinformation and reassure women and healthcare providers worldwide.